Children born to mothers who take antiseizure medications to manage seizures and psychiatric conditions during pregnancy may face increased risks of neurodevelopmental conditions, according to new data from researchers at Drexel's Dornsife School of Public Health.

The findings, published in the journal Nature Communications, showed that children exposed to antiseizure drugs valproate, topiramate, and carbamazepine were linked to specific neurodevelopmental issues.

Children born to mothers who take antiseizure medications to manage seizures and psychiatric conditions during pregnancy may face increased risks of neurodevelopmental conditions, according to new research.